T0	Participants 62 91	metastatic colorectal cancer.
T1	Participants 245 273	metastatic colorectal cancer
T2	Participants 333 400	813 patients with previously untreated metastatic colorectal cancer
T3	Participants 1852 1895	patients with metastatic colorectal cancer.